Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonviral gene therapy.

S Li1, Z Ma

  • 1Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, 639 Salk Hall, Pittsburgh, PA 15213, USA. sol4@pitt.edu

Current Gene Therapy
|July 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT.

European journal of nuclear medicine·1996
Same author

The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a potential actin binding domain and interacts with calmodulin and Rho family GTPases.

Molecular and cellular biology·1996
Same author

Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1996
Same author

Ras1 signaling and transcriptional competence in the R7 cell of Drosophila.

Genes & development·1996
Same author

Localization of gamma-glutamylcysteine synthetase mRNA expression in mouse brain following methylmercury treatment using reverse transcription in situ PCR amplification.

Toxicology and applied pharmacology·1996
Same author

Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells.

Cancer research·1996
Same journal

Identifying Basement Membrane-Related Diagnostic Biomarkers for Rheumatoid Arthritis Through Machine Learning.

Current gene therapy·2026
Same journal

A Multi-Gene Myofibroblast Framework Stratifies Prognostic and Immune Landscapes in HCC.

Current gene therapy·2026
Same journal

Single-cell Transcriptomics Inference of Neutrophil-mast Cell Communication Programs in Periodontitis.

Current gene therapy·2026
Same journal

GULP1 in Ovarian Cancer: Expression, Biological Function, and Clinical Significance.

Current gene therapy·2026
Same journal

Single‑cell Transcriptomic Profiling of Bone Marrow Mesenchymal Stem Cells Reveals Lineage Heterogeneity and Dysregulated Osteoblast Genes in Osteoporosis Versus Osteoarthritis.

Current gene therapy·2026
Same journal

Surface Functionalization of 3D-Printed Porous Ti-6Al-4V Scaffolds with PDA‑mHA-Col I Composite Coating Drives Macrophage Polarization toward the M2 Phenotype and Promotes Immunomodulation: An In Vitro Study.

Current gene therapy·2026
See all related articles

Nonviral vectors show significant progress in gene therapy, matching viral efficiency for various clinical applications. Recent advancements focus on overcoming gene transfer barriers and achieving sustained gene expression.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Nonviral vectors have advanced significantly in the last decade for gene therapy applications.
  • Novel nonviral methods now rival viral vectors in transfection efficiency.
  • Diverse nonviral delivery systems are available for various clinical gene therapy settings.

Purpose of the Study:

  • To review major nonviral vectors used in gene therapy.
  • To highlight recent developments in nonviral vector technology.
  • To discuss progress in understanding gene transfer barriers and achieving sustained gene expression.

Main Methods:

  • Review of current literature on nonviral vectors in gene therapy.
  • Analysis of recent advancements in vector development and application.

Related Experiment Videos

  • Discussion of cellular and in vivo barriers in gene transfer.
  • Examination of strategies for sustained and regulated gene expression.
  • Brief overview of targeted gene repair using nonviral systems.

    • Main Results:

    • Substantial progress in nonviral vector development and application over the past 10 years.
    • Novel nonviral methods achieving transfection efficiencies comparable to viral vectors.
    • Availability of diverse nonviral delivery systems for clinical gene therapy.
    • Increased understanding of cellular and in vivo barriers affecting gene transfer.
    • Advancements in achieving sustained and regulated gene expression.
    • Emerging applications in targeted gene repair.

    Conclusions:

    • Nonviral vectors are increasingly viable and effective tools in gene therapy.
    • Continued research is addressing key challenges in gene transfer and expression.
    • Nonviral systems hold significant promise for future therapeutic applications.